• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    7/18/23 1:47:52 PM ET
    $ABVC
    $ALT
    $APLS
    $AREB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABVC alert in real time by email

     

    During Tuesday's trading, 46 companies set new 52-week lows.

    Interesting Highlights From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was TELUS (NYSE:TU).
    • American Rebel Holdings (NASDAQ:AREB) was the smallest firm on a market cap basis to set a new 52-week low.
    • 9 Meters Biopharma (NASDAQ:NMTR) was the biggest loser, trading down 68.25% to reach its 52-week low.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) saw the sharpest rebound, as shares ascended 0.0%, reversing after hiting a new 52-week low.

    The stocks that set new 52-week lows on Tuesday:

    • Masimo (NASDAQ:MASI) stock drifted down 21.85% on Tuesday morning to hit a new 52-week low of $105.50.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock dropped to a yearly low on Tuesday of $40.04. Shares traded down 18.68%.
    • TELUS Intl (NYSE:TIXT) stock achieved a new 52-week low on Tuesday morning, hitting $9.65 and moving down 1.62%.
    • Mirati Therapeutics (NASDAQ:MRTX) shares set a new yearly low of $33.95 this morning. The stock was down 1.33% on the session.
    • Lumen Technologies (NYSE:LUMN) stock achieved a new 52-week low on Tuesday morning, hitting $1.67 and moving down 0.92%.
    • Nu Skin Enterprises (NYSE:NUS) shares made a new 52-week low of $28.59 on Tuesday. The stock was up 1.88% for the day.
    • Embecta (NASDAQ:EMBC) shares set a new yearly low of $19.91 this morning. The stock was down 1.06% on the session.
    • Leslies (NASDAQ:LESL) shares fell to $5.35 on Tuesday, setting a new 52-week low with a shift of up 5.31%.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $2.59 this morning. The stock was up 0.76% on the session.
    • Mondee Hldgs (NASDAQ:MOND) stock broke to a new 52-week low of $6.42 on Tuesday. Shares of the company traded down 6.27%.
    • Enanta Pharma (NASDAQ:ENTA) shares set a new yearly low of $18.50 this morning. The stock was up 1.54% on the session.
    • Karyopharm Therapeutics (NASDAQ:KPTI) shares reached a new 52-week low of $1.46 on Tuesday morning, moving up 0.98%.
    • Altimmune (NASDAQ:ALT) shares moved up 1.41% on Tuesday to hit a new 52-week low of $3.12, drifting up 1.41%.
    • OrganiGram Holdings (NASDAQ:OGI) shares reached a new 52-week low of $1.43 on Tuesday morning, moving down 0.79%.
    • Ohmyhome (NASDAQ:OMH) stock broke to a new 52-week low of $2.87 on Tuesday. Shares of the company traded down 7.86%.
    • RVL Pharmaceuticals (NASDAQ:RVLP) shares reached a new 52-week low of $0.41 on Tuesday morning, moving down 7.91%.
    • FLJ Group (NASDAQ:FLJ) stock broke to a new 52-week low of $0.20 on Tuesday. Shares of the company traded down 2.36%.
    • CalAmp (NASDAQ:CAMP) stock broke to a new 52-week low of $0.92 on Tuesday. Shares of the company traded down 1.65%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.25. The stock was down 4.55% on the session.
    • Salem Media Group (NASDAQ:SALM) stock set a new 52-week low of $0.88 on Tuesday, moving down 0.03%.
    • AERWINS Technologies (NASDAQ:AWIN) stock dropped to a yearly low on Tuesday of $0.35. Shares traded down 21.36%.
    • 60 Degrees (NASDAQ:SXTP) stock hit $2.61 on Tuesday morning, setting a new 52-week low for a change of down 9.77%.
    • Fangdd Network Group (NASDAQ:DUO) shares moved down 33.67% on Tuesday to hit a new 52-week low of $0.25, drifting down 33.67%.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock drifted 0.0% (flat) on Tuesday morning to hit a new 52-week low of $0.98.
    • Greenbrook TMS (NASDAQ:GBNH) shares moved down 19.27% on Tuesday to hit a new 52-week low of $0.33, drifting down 19.27%.
    • EUDA Health Holdings (NASDAQ:EUDA) shares set a new 52-week low of $0.48. The stock traded down 21.1%.
    • GRI Bio (NASDAQ:GRI) shares made a new 52-week low of $3.67 on Tuesday. The stock was up 6.33% for the day.
    • ABVC BioPharma (NASDAQ:ABVC) shares moved down 7.49% on Tuesday to hit a new 52-week low of $0.34, drifting down 7.49%.
    • Marpai (NASDAQ:MRAI) shares were down 3.9% for the day, having made a 52-week low of $1.52.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.33 on Tuesday morning, setting a new 52-week low for a change of down 4.87%.
    • T Stamp (NASDAQ:IDAI) stock achieved a new 52-week low on Tuesday morning, hitting $0.77 and moving down 4.23%.
    • Spark Networks (NASDAQ:LOV) shares set a new yearly low of $0.21 this morning. The stock was down 6.45% on the session.
    • Integrated Media Tech (NASDAQ:IMTE) stock drifted down 6.83% on Tuesday morning to hit a new 52-week low of $0.25.
    • SuperCom (NASDAQ:SPCB) shares were down 1.1% for the day, having made a 52-week low of $0.92.
    • First Wave BioPharma (NASDAQ:FWBI) shares moved down 13.6% on Tuesday to hit a new 52-week low of $0.67, drifting down 13.6%.
    • 9 Meters Biopharma (NASDAQ:NMTR) shares reached a new 52-week low of $0.18 on Tuesday morning, moving down 68.25%.
    • Galmed Pharmaceuticals (NASDAQ:GLMD) shares set a new 52-week low of $1.31. The stock traded down 1.47%.
    • Biocept (NASDAQ:BIOC) shares were down 3.52% for the day, having made a 52-week low of $1.10.
    • American Rebel Holdings (NASDAQ:AREB) shares moved up 2.79% on Tuesday to hit a new 52-week low of $1.80, drifting up 2.79%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ALT
    $APLS
    $AREB

    CompanyDatePrice TargetRatingAnalyst
    Karyopharm Therapeutics Inc.
    $KPTI
    2/5/2026Overweight
    Cantor Fitzgerald
    Lumen Technologies Inc.
    $LUMN
    2/4/2026Outperform → Mkt Perform
    Raymond James
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Apellis Pharmaceuticals Inc.
    $APLS
    1/21/2026$28.00Neutral → Buy
    BofA Securities
    Leslie's Inc.
    $LESL
    1/15/2026$1.50Equal-Weight → Underweight
    Morgan Stanley
    Telus Corporation
    $TU
    12/11/2025Outperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $ABVC
    $ALT
    $APLS
    $AREB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TELUS secures new 3800 MHz spectrum licences

    Following ISED's residual auction for unsold spectrum, TELUS secures key mid-band spectrum to support and power our growing customer base and continued network evolution for the benefit of Canadians VANCOUVER, BC, Feb. 9, 2026 /CNW/ - TELUS today announced the acquisition of new 3800 MHz spectrum licences in B.C. and Alberta at a cost of $317.6 million. These licences – purchased during ISED's Residual Auction – will enable TELUS to deliver enhanced 5G wireless broadband connectivity to its customers and will continue to optimize the network speeds Canadians have come to expect.

    2/9/26 8:00:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness

    The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity Nu Skin Enterprises Inc. (NYSE:NUS) today announced the relaunch of "The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young," the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin's Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin's science-led innovations — from ageLOC® technology to the company's intelligent beauty and wellne

    2/6/26 1:56:00 PM ET
    $NUS
    Other Pharmaceuticals
    Health Care

    TELUS achieves its 100% renewable and low-emitting electricity target

    The technology company also unveils its new Climate Transition Framework, laying out its approach to reaching net-zero by 2040 with targets validated by global Science Based Targets initiative (SBTi) VANCOUVER, BC, Feb. 6, 2026 /CNW/ - TELUS Corporation is the first Canadian telecom to achieve its target of sourcing 100% of electricity for their global operations from renewable or low-emitting sources as of December 31, 2025. Building on this milestone, TELUS unveiled its new Climate Transition Framework, a comprehensive roadmap to reach net-zero greenhouse gas (GHG) emissions by 2040 while helping to enable Canada's own transition to a low-carbon economy.

    2/6/26 8:15:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    $ABVC
    $ALT
    $APLS
    $AREB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/12/22 6:09:02 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Efficacy

    12/12/22 4:56:01 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Karyopharm Therapeutics

    Cantor Fitzgerald initiated coverage of Karyopharm Therapeutics with a rating of Overweight

    2/5/26 6:58:02 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lumen Technologies downgraded by Raymond James

    Raymond James downgraded Lumen Technologies from Outperform to Mkt Perform

    2/4/26 8:28:23 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Barclays initiated coverage on Apellis Pharmaceuticals with a new price target

    Barclays initiated coverage of Apellis Pharmaceuticals with a rating of Equal Weight and set a new price target of $24.00

    1/28/26 7:15:29 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    SEC Filings

    View All

    SEC Form S-8 filed by Altimmune Inc.

    S-8 - Altimmune, Inc. (0001326190) (Filer)

    2/6/26 4:07:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    American Rebel Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AMERICAN REBEL HOLDINGS INC (0001648087) (Filer)

    2/5/26 5:30:22 PM ET
    $AREB
    Plastic Products
    Industrials

    SEC Form PRE 14A filed by ABVC BioPharma Inc.

    PRE 14A - ABVC BIOPHARMA, INC. (0001173313) (Filer)

    2/5/26 5:29:33 PM ET
    $ABVC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Johnson Kathleen E bought $499,925 worth of shares (78,685 units at $6.35), increasing direct ownership by 0.93% to 8,562,582 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/5/26 5:34:09 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/9/26 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Sohn Catherine A. bought $2,118 worth of shares (500 units at $4.24), increasing direct ownership by 50% to 1,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/5/26 4:05:39 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Revenue Officer Sharritts Jeffery S. was granted 576,282 shares (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/6/26 5:35:03 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    SEC Form 3 filed by new insider Sharritts Jeffery S.

    3 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/6/26 5:33:18 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    President & CEO Johnson Kathleen E bought $499,925 worth of shares (78,685 units at $6.35), increasing direct ownership by 0.93% to 8,562,582 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/5/26 5:34:09 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $ABVC
    $ALT
    $APLS
    $AREB
    Financials

    Live finance-specific insights

    View All

    TELUS secures new 3800 MHz spectrum licences

    Following ISED's residual auction for unsold spectrum, TELUS secures key mid-band spectrum to support and power our growing customer base and continued network evolution for the benefit of Canadians VANCOUVER, BC, Feb. 9, 2026 /CNW/ - TELUS today announced the acquisition of new 3800 MHz spectrum licences in B.C. and Alberta at a cost of $317.6 million. These licences – purchased during ISED's Residual Auction – will enable TELUS to deliver enhanced 5G wireless broadband connectivity to its customers and will continue to optimize the network speeds Canadians have come to expect.

    2/9/26 8:00:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

    -- Conference Call Scheduled for Thursday, February 12, 2026, at 8:00 a.m. ET -- NEWTON, Mass., Feb. 5, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, February 12, 2026, to discuss the financial results and other company updates. To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to b

    2/5/26 7:30:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

    PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results. Visit the company's Investor Relations website at http://investors.embecta.com to view the detailed first quarter fiscal 2026 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible here, or access the teleconference here. A webcast replay of the call will be available be

    2/5/26 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Leadership Updates

    Live Leadership Updates

    View All

    Lumen Technologies Appoints Jeff Sharritts as Chief Revenue Officer

    Veteran leader to deepen customer relationships, sharpen execution, and scale company's commercial engine in Lumen's next phase of transformation Lumen Technologies (NYSE: LUMN) today announced that Jeff Sharritts has been appointed Executive Vice President and Chief Revenue Officer, effective Feb. 4, 2026. He will report to Lumen CEO Kate Johnson and will lead Lumen's commercial strategy, including the Acceleration and Growth Team, with a focus on deepening customer relationships and driving profitable growth for the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203640994/en/LUMN) as EVP and Chief Revenue Officer

    2/3/26 4:01:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $ABVC
    $ALT
    $APLS
    $AREB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care